5α-Tetrahydrocorticosterone: A topical anti-inflammatory glucocorticoid with an improved therapeutic index in a murine model of dermatitis

被引:2
作者
Livingstone, Dawn Elizabeth Watson [1 ,2 ,4 ]
Sooy, Karen [1 ]
Sykes, Catherine [1 ]
Webster, Scott Peter [1 ]
Walker, Brian Robert [1 ,3 ]
Andrew, Ruth [1 ]
机构
[1] Univ Edinburgh, Univ British Heart Fdn, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Scotland
[2] Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh, Scotland
[3] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, England
[4] Univ Edinburgh, Ctr Discovery Brain Sci, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Scotland
基金
英国惠康基金; 英国医学研究理事会;
关键词
5; alpha-tetrahydrocorticosterone; anti-inflammatory; dissociated steroid; glucocorticoid; selective glucocorticoid receptor modulator; RECEPTOR AGONIST; 5-ALPHA-REDUCED GLUCOCORTICOIDS; INDUCED ATROPHY; SKIN; METABOLISM; MAPRACORAT; EFFICACY; INSIGHT; BINDING; DESIGN;
D O I
10.1111/bph.16285
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Purpose: Glucocorticoids are powerful anti-inflammatory drugs, but are associated with many side-effects. Topical application in atopic dermatitis leads to skin thinning, metabolic changes, and adrenal suppression. 5 alpha-Tetrahydrocorticosterone (5 alpha THB) is a potential selective anti-inflammatory with reduced metabolic effects. Here, the efficacy and side-effect profile of 5 alpha THB were compared with hydrocortisone in preclinical models of irritant dermatitis.Experimental Approach: Acute irritant dermatitis was invoked in ear skin of male C57BL/6 mice with a single topical application of croton oil. Inflammation was assessed as oedema via ear weight following treatment with 5 alpha THB and hydrocortisone. Side-effects of 5 alpha THB and hydrocortisone were assessed following chronic topical steroid treatment (28 days) to non-irritated skin. Skin thinning was quantified longitudinally by caliper measurements and summarily by qPCR for transcripts for genes involved in extracellular matrix homeostasis; systemic effects of topical steroid administration also were assessed. Clearance of 5 alpha THB and hydrocortisone were measured following intravenous and oral administration.Key Results: 5 alpha THB suppressed ear swelling in mice, with ED50 similar to hydrocortisone (23 mu g vs. 13 mu g). Chronic application of 5 alpha THB did not cause skin thinning, adrenal atrophy, weight loss, thymic involution, or raised insulin levels, all of which were observed with topical hydrocortisone. Transcripts for genes involved in collagen synthesis and stability were adversely affected by all doses of hydrocortisone, but only by the highest dose of 5 alpha THB (8x ED50). 5 alpha THB was rapidly cleared from the systemic circulation.Conclusions and Implications: Topical 5 alpha THB has potential to treat inflammatory skin conditions, particularly in areas of delicate skin.
引用
收藏
页码:1256 / 1267
页数:12
相关论文
共 51 条
[1]   Comparison of mechanisms of angiostasis caused by the anti-inflammatory steroid 5?-tetrahydrocorticosterone versus conventional glucocorticoids [J].
Abernethie, Amber J. ;
Gastaldello, Annalisa ;
Maltese, Giorgia ;
Morgan, Ruth A. ;
McInnes, Kerry J. ;
Small, Gary R. ;
Walker, Brian R. ;
Livingstone, Dawn EW. ;
Hadoke, Patrick WF. ;
Andrew, Ruth .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 929
[2]   Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 [J].
Abraham, Sonya M. ;
Lawrence, Toby ;
Kleiman, Anna ;
Warden, Paul ;
Medghalchi, Mino ;
Tuckermann, Jan ;
Saklatvala, Jeremy ;
Clark, Andrew R. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (08) :1883-1889
[3]   The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies [J].
Abuabara, K. ;
Yu, A. M. ;
Okhovat, J. -P. ;
Allen, I. E. ;
Langan, S. M. .
ALLERGY, 2018, 73 (03) :696-704
[4]   Obesity and gender influence cortisol secretion and metabolism in man [J].
Andrew, R ;
Phillips, DIW ;
Walker, BR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) :1806-1809
[5]   The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs [J].
Baumer, Wolfgang ;
Rossbach, Kristine ;
Schmidt, Bernard H. .
VETERINARY DERMATOLOGY, 2017, 28 (01) :46-+
[6]   Epidermal glucocorticoid and mineralocorticoid receptors act cooperatively to regulate epidermal development and counteract skin inflammation [J].
Bigas, Judit ;
Sevilla, Lisa M. ;
Carceller, Elena ;
Boix, Julia ;
Perez, Paloma .
CELL DEATH & DISEASE, 2018, 9
[7]   Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor [J].
Biggadike, Keith ;
Bledsoe, Randy K. ;
Coe, Diane M. ;
Cooper, Tony W. J. ;
House, David ;
Iannone, Marie A. ;
Macdonald, Simon J. F. ;
Madauss, Kevin P. ;
McLay, Iain M. ;
Shipley, Tracy J. ;
Taylor, Simon J. ;
Tran, Thuy B. ;
Uings, Iain J. ;
Weller, Victoria ;
Williams, Shawn P. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (43) :18114-18119
[8]   Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight [J].
Billich, A ;
Vyplel, H ;
Grassberger, M ;
Schmook, FP ;
Steck, A ;
Stuetz, A .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (09) :3157-3167
[9]   Percutaneous absorption of drugs used in atopic eczema:: pimecrolimus permeates less through skin than corticosteroids and tacrolimus [J].
Billich, A ;
Aschauer, H ;
Aszódi, A ;
Stuetz, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 269 (01) :29-35
[10]  
Cain D., 2023, IUPHARBPS GUIDE PHAR, DOI [10.2218/gtopdb/F98/2023.1, DOI 10.2218/GTOPDB/F98/2023.1]